SCHEMBL13098745

SCHEMBL13098745

c1ccc(-n2c(-c3cccc(-c4c5ccccc5c(-c5ccc6cc(-c7c8ccccc8c(-c8ccc9ccccc9c8)c8ccccc78)ccc6c5)c5ccccc45)c3)nc3ccccc32)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.50
ESR2 Q92731 2/20 0.50
HDAC1 Q13547 3/20 0.47
HDAC8 Q9BY41 3/20 0.47
HDAC6 Q9UBN7 3/20 0.47
MAPK10 P53779 5/20 0.47
PTGER4 P35408 1/20 0.45
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
GRIA1 P42261 1/20 0.43
CACNG8 Q8WXS5 1/20 0.43
CACNG2 Q9Y698 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
GAA P10253 2/20 0.43
HSP90AA1 P07900 1/20 0.41
MAPT P10636 1/20 0.41
RECQL P46063 1/20 0.41
PRKACA P17612 1/20 0.41
RPS6KB1 P23443 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL338275 1.00 ESR1 (0.50) ESR1ESR2HDAC1HDAC8HDAC6
SCHEMBL29444793 1.00 ESR1 (0.50) ESR1ESR2HDAC1HDAC8HDAC6
SCHEMBL24812207 0.99 ESR1 (0.49) ESR1ESR2HDAC1HDAC8HDAC6
SCHEMBL14506133 0.99 ESR1 (0.49) ESR1ESR2HDAC1HDAC8HDAC6
SCHEMBL24811902 0.96 ESR1 (0.47) ESR1ESR2HDAC1HDAC8HDAC6
SCHEMBL12571630 0.96 ESR1 (0.47) ESR1ESR2HDAC1HDAC8HDAC6
SCHEMBL14506002 0.96 ESR1 (0.51) ESR1ESR2HDAC1HDAC8HDAC6
SCHEMBL24812242 0.96 ESR1 (0.50) ESR1ESR2HDAC1HDAC8HDAC6
SCHEMBL12887916 0.95 ESR1 (0.46) ESR1ESR2HDAC1HDAC8HDAC6
SCHEMBL12571693 0.95 ESR1 (0.46) ESR1ESR2HDAC1HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8957407-B2 Anthracene derivatives, preparation method thereof and organic light emitting diode using the same LG CHEM, LTD. (KR) 2015-02-17 US disclosed
US-8957407-B2 Anthracene derivatives, preparation method thereof and organic light emitting diode using the same LG CHEM, LTD. (KR) 2015-02-17 US disclosed
US-20100252817-A1 New Anthracene Derivatives, Preparation Method Thereof and Organic Light Emitting Diode Using the Same LG CHEM. LTD. (KR) 2010-10-07 US disclosed
US-20100252817-A1 New Anthracene Derivatives, Preparation Method Thereof and Organic Light Emitting Diode Using the Same LG CHEM. LTD. (KR) 2010-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100252817-A1 New Anthracene Derivatives, Preparation Method Thereof and Organic Light Emitting Diode Using the Same CYBA, XPOT, TOMM22 ESR1 194/4885ESR2 1002/4885HDAC1 4343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.